HK-listed Austar Lifesciences sees worst day in over 6 months

Austar Lifesciences

16/02/2021 07:27

** Shares of pharmaceutical manufacturer Austar Lifesciences
Ltd  6118.HK  fall as much as 17.4% to HK$5, their lowest since
Jan 18
    ** Stock on track for the second session of decline and its
worst day since Aug 4; among the 30 biggest percentage decliners
on the Hong Kong bourse 
    ** Beijing-based firm plans to sell its 60% stake in
bioprocess container-making venture PALL-AUSTAR Lifesciences Ltd
to a unit of Danaher Corp  DHR.N  for $34.5 mln  urn:newsml:reuters.com:*:nFWN2KK05H
    ** Co expects a 160 mln yuan ($24.79 mln) gain from the
disposal 
    ** The Hong Kong Hang Seng Commerce & Industry Index  .HSNC 
rises 1%
    ** The Hang Seng China enterprises index  .HSCE  rises 1.3%
and the benchmark index  .HSI  surges 1.6%


($1 = 6.4542 Chinese yuan renminbi)

 (Reuters Messaging: donny.kwok.thomsonreuters.com@reuters.net)